Roche
Roche appoints Karen Lackey head of medicinal chemistry
August 3, 2010Manufacturing and Production, Research and Development Roche, appointment, manufacturing and production, research and development
Karen Lackey has been appointed vice-president and head of medicinal chemistry by Roche. She will be based at the company’s …
Roche sees slow sales amid market pressures
July 22, 2010Sales and Marketing 2010 financials, Q2, Roche
Roche has posted average first half year results with pharma sales that showed only low single digit growth. They showed …
FDA advised to halt Avastin breast cancer use
July 21, 2010Sales and Marketing Roche, avastin
In a hammer blow to Roche, an influential Food and Drug Administration vote has gone against its cancer drug Avastin. …
Roche submits new version of Herceptin for US approval
July 7, 2010Research and Development, Sales and Marketing Herceptin, Roche, breast cancer
Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …
NICE set to block Herceptin for gastric cancer
July 6, 2010Sales and Marketing Herceptin, NICE, Roche, gastric cancer
NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …
Ovarian cancer trial boost for Avastin
July 5, 2010Research and Development Roche, avastin, ovarian cancer
Roche’s blockbuster oncology drug Avastin has met its primary endpoint of improving progression-free survival in women with ovarian cancer in …
NICE thumbs up for Roche arthritis drug
July 2, 2010Sales and Marketing NICE, RoActemra, Roche
NICE has given preliminary approval to Roche’s RoActemra as an additional option for the treatment of moderate to severe rheumatoid …
NICE rejects Tarceva maintenance treatment
June 17, 2010Sales and Marketing NICE, NSCLC, Roche, Tarceva, lung cancer
Roche’s Tarceva should not be used in lung cancer patients who have already been treated and whose disease remains stable, …
Roche forms translational medicine research hub
May 26, 2010Research and Development Roche, Switzerland, academic research, translational
Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what …
Roche discontinues arthritis drug trials
May 20, 2010Sales and Marketing RA, Roche
Roche and Biogen Idec will discontinue clinical trials for rheumatoid arthritis drug ocrelizumab. Development of the RA treatment was halted …
India revokes Roche’s Valcyte patent
May 19, 2010Sales and Marketing India, Roche, patents
Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …
Emerging markets lift Roche in Q1
April 16, 2010Sales and Marketing Roche, emerging markets
Roche saw its sales grow 9% overall in the first quarter, with emerging markets medicines revenues showing a healthy 38% …
Roche buys insulin patch company
April 13, 2010Research and Development Diagnostics, Roche, diabetes
Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market. Medingo, formerly a …
Frank Pitzer made chief executive at NimbleGen
April 7, 2010Research and Development NimbleGen, Roche, appointment, research and development
Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …
Roche’s Xeloda widens licence
April 1, 2010Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer
Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
